Human immunodeficiency virus neutralizing antibodies and methods of use thereof

US9783594B2 · kind B2 · utility

Assignees

• The Rockefeller University · US
• CALIFORNIA INSTITUTE OF TECHNOLOGY · US

Inventors

• Johannes Scheid · New York, US
• Michel Nussenzweig · New York, US
• Pamela J. Bjorkman · Altadena, US
• Ron Diskin · Rehovot, IL

Key dates

• Filing date: May 17, 2012
• Grant date: Oct 10, 2017
• Expiry date: May 30, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides broadly neutralizing antibodies directed to epitopes of Human Immunodeficiency Virus, or HIV. The invention further provides compositions containing HIV antibodies used for prophylaxis, and methods for diagnosis and treatment of HIV infection.